May 30, 2023

BIO 2023 – The Massachusetts Pavilion

Programming Agenda

Tuesday, June 6

12:15 – 12:45 p.m. | MassNextGen Panel 
With the support of industry sponsors, the MLSC is proud to launch the next iteration of the MassNextGen program to support a larger pool of entrepreneurs with a more inclusive focus. Hear firsthand from MassNextGen Anchor Platinum Sponsor Takeda on the importance of investing in MassNextGen, entrepreneurs Virginia Burger and Laura Kleiman on how MassNextGen has impacted their company’s success and entrepreneurial growth, and MLSC President and CEO Kenn Turner on his vision for the next iteration of MassNextGen. 

Wednesday, June 7

1 – 1:15 p.m. | Possible Talk: Women’s Health 
Nanopath is a molecular diagnostics company that aims to disrupt traditional testing methodologies. The company’s goal is to equitably improve the lives of patients, starting with women, by providing actionable molecular information within a single office visit. Learn more about Dr. Burklund and Dr. Tadimety’s work and perspective on the women’s health landscape. 

2 – 2:30 p.m. | Team Massachusetts Panel
The passionate members of Team Massachusetts are excited to share with you why the Massachusetts ecosystem is the ideal location to grow your thriving business, what resources the Commonwealth can offer to help you at any stage, and how to take the next steps. 

3 – 3:30 p.m. | Building Workforce Partnerships & Making New Paths 
Massachusetts continues to be a leader in developing the strongest life sciences workforce through the culmination of academia and training partners closely working with industry. Learn more about the partnership between one of the largest employers in Massachusetts, Takeda, and a workforce development pioneer, Jewish Vocational Service (JVS). 

3:45 – 4 p.m. | Possible Talk: Health Equity 
Under the leadership of Dr. Reginald Swift, Rubix Life Sciences is powering the world’s healthcare data with diverse patient analytics. They aim to tackle disease diagnosis disparities and therapeutic outcomes for underrepresented patients. Learn more about Rubix LS’ work and how they are evolving the healthy equity landscape to serve all patients.